| PF | RP | BP | GH | VT | SF | RE | MH | Total SF-36 |
---|---|---|---|---|---|---|---|---|---|
Age | |||||||||
R2 | 0.166 | 0.025 | 0.045 | 0.037 | 0.068 | 0.053 | 0.035 | 0.007 | 0.078 |
β | − 0.047 | − 0.159 | − 0.211 | − 0.193 | − 0.261 | − 0.229 | − 0.187 | − 0.085 | − 0.280 |
P | 0.001 | 0.028 | 0.003 | 0.007 | 0.001 | 0.001 | 0.009 | 0.244 | 0.001 |
Disease duration | |||||||||
R2 | 0.089 | 0.033 | 0.058 | 0.048 | 0.061 | 0.063 | 0.028 | 0.000 | 0.069 |
β | − 0.298 | − 0.182 | − 0.241 | − 0.218 | − 0.247 | − 0.251 | − 0.168 | − 0.016 | − 0.263 |
P | 0.001 | 0.012 | 0.001 | 0.002 | 0.001 | 0.001 | 0.020 | 0.829 | 0.001 |
DAS28 | |||||||||
R2 | 0.619 | 0.270 | 0.672 | 0.317 | 0.412 | 0.512 | 0.210 | 0.232 | 0.632 |
β | − 0.787 | − 0.520 | − 0.820 | − 0.563 | − 0.641 | − 0.716 | − 0.459 | − 0.481 | − 0.795 |
P | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 |
BIPQ–1 Consequences | |||||||||
R2 | 0.221 | 0.102 | 0.249 | 0.187 | 0.231 | 0.199 | 0.073 | 0.142 | 0.266 |
β | − 0.470 | − 0.319 | − 0.499 | − 0.433 | − 0.481 | − 0.446 | − 0.270 | − 0.377 | − 0.516 |
P | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 |
BIPQ–2 Timeline | |||||||||
R2 | 0.055 | 0.083 | 0.111 | 0.100 | 0.057 | 0.085 | 0.066 | 0.013 | 0.114 |
β | − 0.235 | − 0.288 | − 0.334 | − 0.317 | − 0.240 | − 0.291 | − 0.256 | − 0.114 | − 0.338 |
P | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.115 | 0.001 |
BIPQ–3 Personal control | |||||||||
R2 | 0.113 | 0.031 | 0.090 | 0.142 | 0.102 | 0.104 | 0.059 | 0.038 | 0.127 |
β | 0.336 | 0.175 | 0.299 | 0.377 | 0.320 | 0.322 | 0.243 | 0.196 | 0.356 |
P | 0.001 | 0.015 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.007 | 0.001 |
BIPQ–4 Treatment control | |||||||||
R2 | 0.006 | 0.014 | 0.002 | 0.023 | 0.010 | 0.007 | 0.025 | 0.004 | 0.018 |
β | 0.076 | 0.120 | 0.049 | 0.153 | 0.101 | 0.085 | 0.159 | 0.059 | 0.134 |
P | 0.298 | 0.097 | 0.499 | 0.035 | 0.165 | 0.242 | 0.028 | 0.414 | 0.066 |
BIPQ–5 Identity | |||||||||
R2 | 0.257 | 0.174 | 0.300 | 0.173 | 0.221 | 0.244 | 0.138 | 0.126 | 0.330 |
β | − 0.507 | − 0.417 | − 0.547 | − 0.416 | − 0.470 | − 0.494 | − 0.372 | − 0.355 | − 0.574 |
P | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 |
BIPQ–6 Illness concern | |||||||||
R2 | 0.008 | 0.020 | 0.023 | 0.028 | 0.021 | 0.007 | 0.017 | 0.006 | 0.025 |
β | − 0.090 | − 0.141 | − 0.151 | − 0.166 | − 0.146 | − 0.082 | − 0.131 | − 0.079 | − 0.158 |
P | 0.216 | 0.052 | 0.037 | 0.022 | 0.044 | 0.261 | 0.071 | 0.276 | 0.029 |
BIPQ–7 Coherence | |||||||||
R2 | 0.030 | 0.000 | 0.008 | 0.000 | 0.002 | 0.016 | 0.001 | 0.019 | 0.009 |
β | 0.174 | − 0.018 | 0.090 | − 0.003 | 0.048 | 0.128 | 0.038 | 0.137 | 0.093 |
P | 0.016 | 0.802 | 0.216 | 0.963 | 0.511 | 0.078 | 0.601 | 0.059 | 0.203 |
BIPQ–8 Emotional response | |||||||||
R2 | 0.235 | 0.158 | 0.276 | 0.245 | 0.270 | 0.282 | 0.165 | 0.266 | 0.376 |
β | − 0.484 | − 0.397 | − 0.525 | − 0.495 | − 0.519 | − 0.531 | − 0.406 | − 0.515 | − 0.613 |
P | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 |
Overall BIPQ | |||||||||
R2 | 0.350 | 0.206 | 0.386 | 0.334 | 0.333 | 0.354 | 0.210 | 0.212 | 0.476 |
β | − 0.592 | − 0.454 | − 0.621 | − 0.578 | − 0.577 | − 0.595 | − 0.458 | − 0.461 | − 0.690 |
P | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 |